Explore

Homepage

Get back to the homepage

Our science

Clients & partners say about us

Services

See all we can do for you

Our Mission

What we're working for

The team

Team members and partners

Latest news

Read the news and updates

Our Pipelines

ADC Research

Therapeutic delivery system

Vaccines Research

Treat and cure pathologies

Drug Design

Target biological pathways

Peptides Research

Mainly target the cancer cells

Bioconjugation

Turns biomolecule into vehicule

w

WORK WITH US

Our contract research organization, is putting it's Canadian 🇨🇦 lab. Benefit from our talent.

More details.

ACCELERATE, DEVELOP & CREATE

Located in Canada, our team is ready to be part of yours. Makes WASSC a cost-effective contract research organization.

See our services

Address

2650 Maximilien-Chagnon,
Sherbrooke, Qc, Can, J1E 0M8

Contact

(819) 565-4531
info@wassctechnologie.com

INNOVATION AND CONTRACT RESEARCH ORGANIZATION

WASSC TECH is a biopharmaceutic research company focused on the development of antibody drug conjugate (ADC) against cancer and vaccine that’s offering its expertise and equipment as a contract research organization to help companies with their challenges. A multidisciplinary team composed of chemist, bio-chemist and biologist that takes different angles to tackle their obstacles and find solutions!

#why-wassc? ADC'S LATEST TECHNOLOGY !

WASSC Tech is a company dedicated to the advancement of antibody and ADC development and vaccine creation, specializing on site-specific bioconjugation, drug design, and related fields. One of our main objectives is to establish a novel category of ADCs, overseeing every stage from development to manufacturing. Moreover, WASSC’s overarching mission involves the creation of technologies for precise site-specific conjugation, no matter the biomolecule involved.

OUR EXPERTISE AT YOUR SERVICE

All the tools that we have developed internally are now available for your company. Ask us a quote !

See below all the services we offer.

✔️ADC DESIGN AND OPTIMIZATION SERVICES ✔️BIOCONJUGATION SERVICES
✔️PEPTIDES SERVICES ✔️DRUG DESIGN SERVICES
✔️BIOANALYSIS AND CHEMICAL SERVICES ✔️FORMULATION SERVICES
✔️BIOLOGY : PROTEIN AND MOLECULAR SERVICES ✔️FORMULATION SERVICES
✔️CONSULTATION SERVICES


Dr. Simon Beaudoin PhD, Biochemist

– our ceo and founder

My passion for science is what makes WASSC’s innovative!

Dr. Simon Beaudoin, CEO of WASSC Technologies, CTSO of Defense Therapeutics and Co-Founder of Defence Therapeutics.

Simon has received a PhD in biochemistry at Sherbrooke’s University in 2013. His expertise in biochemistry, molecular and cellular biology greatly contributed to the conceptualization, realization and valorization of the Accum technology. A platform publicly traded on TSX (Defence Therapeutics).

With a strong expertise in the area of bio-conjugation and particularly, in the development and optimization of ADC, vaccines and radio-immuno-conjugates for diagnostic applications. His impressive work has been covered in many highly respected scientific journals. Simon is also the recipient of 15 peer-reviewed awards and scholarships.

Inventor of several patent-pending technologies (8) related to vaccines, ADC and drug delivery systems. Illustrating the impact of his work on the scientific community. Simon is also the recipient of life science entrepreneurship grants and certifications. The reach of his projects allowed for multiple collaborations with internationally renowned academic and industrial partners in the field of ADCs and vaccines as a Key Opinion Leader. »

– we can assist you

Accelerate, Develop, Create !

– Our multidisciplinary team

Board Leaders, employees & partners.

Simon Beaudoin

"CEO, PhD Biochemistry"

Simon has received a PhD in biochemistry at Sherbrooke’s University in 2013. His expertise in biochemistry, molecular and cellular...
Read More
Simon Beaudoin

"CEO, PhD Biochemistry"

Simon has received a PhD in biochemistry at Sherbrooke’s University in 2013. His expertise in biochemistry, molecular and cellular biology greatly contributed to the conceptualization, realization and valorization of the Accum™ technology. A platform publicly traded on TSX (Defence Therapeutics). With a strong expertise in the area of bio-conjugation and particularly, in the development and optimization of ADC, vaccines and radio-immuno-conjugates for diagnostic applications. His impressive work has been covered in many highly respected scientific journals. Simon is also the recipient of 15 peer-reviewed awards and scholarships. Inventor of several patent-pending technologies (8) related to vaccines, ADC and drug delivery systems. Illustrating the impact of his work on the scientific community. Simon is also the recipient of life science entrepreneurship grants and certifications. The reach of his projects allowed for multiple collaborations with internationally renowned academic and industrial partners in the field of ADCs and vaccines as a Key Opinion Leader. »
Simon Beaudoin
Simon Beaudoin
Dominique Comtois

"Analytical chemist"

Dominique is a analytical chemist having recently obtained her Bachelor degree in Chemistry with a specialization in analytical chemistry (...
Read More
Dominique Comtois

"Analytical chemist"

Dominique is a analytical chemist having recently obtained her Bachelor degree in Chemistry with a specialization in analytical chemistry (may 2023). She is actually working at WASSC Technologies Inc for one & half year and take advantage of her expertise as a chemist as well as her expertise in biology that she acquired during her College degree in laboratory biotechnology technique in 2019. His multidisciplinary background has allowed her to understand as much biological than chemical aspects (organic and analytical chemistry). Her passion for chromatography such as HPLC-MS and GC has resulted in her currently working in the company's bioanalysis and chemistry platform.
Dominique Comtois
Dominique Comtois
Dr. Alireza Roostaee

"PhD Biochemistry"

Dr. Alireza Roostaee is a biochemist with knowledge and experience in the fields of medical biochemistry, epigenetics, neuro-biochemistry,...
Read More
Dr. Alireza Roostaee

"PhD Biochemistry"

Dr. Alireza Roostaee is a biochemist with knowledge and experience in the fields of medical biochemistry, epigenetics, neuro-biochemistry, cell and molecular biology and structural biology. He is holding a Ph.D. in biochemistry from the University of Sherbrooke. His research led to the identification of molecular mechanisms of neurodegenerative disorders. His works have been published in the journals of high impact and have been winners of several awards and scholarships. The research of his 2 post-doctorates were centred around the mechanism of differentiation of stem cells through modification of histone proteins. Dr. Roostaee had been the director of research and innovation in the Laboratory M2 Inc. for 4 years, during which he designed new experimental concepts to produce functional nano-particle formulations as small as 1 nm. He has outstanding expertise in the fields of protein expression and purification in different formulations. This includes different methods of protein and polypeptide production using native or re-folding purification protocols.  He is now working as a scientist for research project development, experimental designs, consulting, and supervising experimentations. His experimental expertise supports important projects such as formulation, gene cloning, protein expression and purification, and molecular and cellular biology aspects of the current research projects with the aim of developing anti-cancer drugs able to perform in high efficiencies with minimum or no side effects. Dr. Roostaee is also responsible for preparing and editing the scientific reports, grant proposals as well as R&D applications for the research credit and any other scientific and administrative communications.
Dr. Alireza Roostaee
Dr. Alireza Roostaee